The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?: A Systematic Review
Open accessAbstract
BACKGROUND: Financial payments from the drug industry to U.S. physicians are common. Payments may influence physicians' clinical decision making and drug prescribing. PURPOSE: To evaluate whether receipt of payments from the drug industry is associated with physician prescribing practices. DATA SOURCES: MEDLINE (Ovid), Embase, the Cochrane Library, Web of Science, and EconLit were searched without language restrictions. The search had no limiting start date and concluded on 16 September 2020. STUDY SELECTION: Studies that estimated the association between receipt of industry payments (exposure) and prescribing (outcome). DATA EXTRACTION: Pairs of reviewers extracted the primary analysis or analyses from each study and evaluated risk of bias (ROB). DATA SYNTHESIS: = 6) had a mix of positive and null findings. No study had only null findings. Of 101 individual analyses, 89 identified a positive association. Payments were associated with increased prescribing of the paying company's drug, increased prescribing costs, and increased prescribing of branded drugs. Nine studies assessed and found evidence of a temporal association; 25 assessed and found evidence of a dose-response relationship. LIMITATION: The design was observational, 21 of 36 studies had serious ROB, and publication bias was possible. CONCLUSION: The association between industry payments and physician prescribing was consistent across all studies that have evaluated this association. Findings regarding a temporal association and dose-response suggest a causal relationship. PRIMARY FUNDING SOURCE: National Cancer Institute.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.021 · Cited by 5,700
De-duplication of database search results for systematic reviews in EndNote
Bramer, W. M., Giustini, D., de Jonge, G. B., Holland, L., & Bekhuis, T. (2016) · Journal of the Medical Library Association : JMLA · doi:10.3163/1536-5050.104.3.014 · Cited by 2,103
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., et al. (2006) · JAMA · doi:10.1001/jama.295.4.429 · Cited by 695
Self-citationSpurling, G. K., Mansfield, P. R., Montgomery, B. D., Lexchin, J., Doust, J., Othman, N., & Vitry, A. I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000352 · Cited by 526
DeJong, C., Aguilar, T., Tseng, C.-W., Lin, G. A., Boscardin, W. J., & Dudley, R. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2765 · Cited by 517
Chren, M. M. (1994) · JAMA · doi:10.1001/jama.271.9.684 · Cited by 397
The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns
Orlowski, J. P., & Wateska, L. (1992) · Chest · doi:10.1378/chest.102.1.270 · Cited by 384
Medical Marketing in the United States, 1997-2016
Schwartz, L. M., & Woloshin, S. (2019) · JAMA · doi:10.1001/jama.2018.19320 · Cited by 379
Fickweiler, F., Fickweiler, W., & Urbach, E. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016408 · Cited by 293
Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin, J. (1993) · Europe PMC (PubMed Central) · Cited by 271
Types and Distribution of Payments From Industry to Physicians in 2015
Tringale, K. R., Marshall, D., Mackey, T. K., Connor, M., Murphy, J. D., & Hattangadi-Gluth, J. A. (2017) · JAMA · doi:10.1001/jama.2017.3091 · Cited by 232
Hadland, S. E., Rivera-Aguirre, A., Marshall, B. D. L., & Cerdá, M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6007 · Cited by 225
Yeh, J. S., Franklin, J. M., Avorn, J., Landon, J., & Kesselheim, A. S. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1709 · Cited by 218
Physicians under the Influence: Social Psychology and Industry Marketing Strategies
Sah, S., & Fugh-Berman, A. (2013) · Journal of Law, Medicine & Ethics · doi:10.1111/jlme.12076 · Cited by 192
Brax, H., Fadlallah, R., Alkhaled, L., Kahale, L. A., Nas, H., El‐Jardali, F., & Akl, E. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175493 · Cited by 190
Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices
OLDANI, M. J. (2004) · Medical Anthropology Quarterly · doi:10.1525/maq.2004.18.3.325 · Cited by 177
Everyone's a Little Bit Biased (Even Physicians)
Cain, D. M. (2008) · JAMA · doi:10.1001/jama.299.24.2893 · Cited by 149
Fleischman, W. M., Agrawal, S., King, M. D., Venkatesh, A. K., Krumholz, H. M., McKee, D., Brown, D., & Ross, J. S. (2016) · BMJ · doi:10.1136/bmj.i4189 · Cited by 145
Hadland, S. E., Cerdá, M., Li, Y., Krieger, M. S., & Marshall, B. D. L. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.1999 · Cited by 137
Are Gifts From Pharmaceutical Companies Ethically Problematic? A Survey of Physicians
Brett, A. S., Burr, W., & Moloo, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2213 · Cited by 136
Factors Influencing Prescribing Decisions of Physicians: A Review
Davari, M., Khorasani, E., & Tigabu, B. M. (1970) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v28i6.15 · Cited by 124
Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn, J., Blood, E., Winer, E., & Partridge, A. (2007) · Cancer · doi:10.1002/cncr.22528 · Cited by 123
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
Perlis, R. H., & Perlis, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155474 · Cited by 118
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors
Mitchell, A. P., Basch, E., & Dusetzina, S. B. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.2710 · Cited by 116
Self-citationCash interests taint drug advice
Taylor, R., & Giles, J. (2005) · Nature · doi:10.1038/4371070a · Cited by 111
Samuel, A. M., Webb, M. L., Lukasiewicz, A. M., Bohl, D. D., Basques, B. A., Russo, G. S., Rathi, V. K., & Grauer, J. N. (2015) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-015-4413-8 · Cited by 108
Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., Worley, A. V., & Gurwitz, J. H. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0989-6 · Cited by 89
Physician Attitudes Toward Industry: A View Across the Specialties
Korenstein, D. R., Keyhani, S., & Ross, J. S. (2010) · Archives of Surgery · doi:10.1001/archsurg.2010.75 · Cited by 87
Self-citationInoue, K., Blumenthal, D. M., Elashoff, D. A., & Tsugawa, Y. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031010 · Cited by 79
Sharma, M., Vadhariya, A., Johnson, M. L., Marcum, Z. A., & Holmes, H. M. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3043-8 · Cited by 73
Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia
Wood, S. F., Podrasky, J., McMonagle, M. A., Raveendran, J. A., Bysshe, T., Hogenmiller, A., & Fugh‐Berman, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186060 · Cited by 72
Taylor, S. C., Huecker, J. B., Gordon, M. O., Vollman, D. E., & Apte, R. S. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.1678 · Cited by 67
“Let the Sunshine In”: The Impact of Industry Payment Disclosure on Physician Prescription Behavior
Guo, T., Sriram, S., & Manchanda, P. (2020) · Marketing Science · doi:10.1287/mksc.2019.1181 · Cited by 65
Mitchell, A. P., Winn, A. N., & Dusetzina, S. B. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0776 · Cited by 64
Self-citationTibau, A., Bedard, P. L., Srikanthan, A., Ethier, J.-L., Vera-Badillo, F., Templeton, A. J., Ocaña, A., Šeruga, B., Barnadas, A., & Amir, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.8898 · Cited by 59
Drug Diffusion through Peer Networks: The Influence of Industry Payments
Agha, L., & Zeltzer, D. (2022) · American Economic Journal Economic Policy · doi:10.1257/pol.20200044 · Cited by 54
US drug marketing: how does promotion correspond with health value?
Greenway, T., & Ross, J. S. (2017) · BMJ · doi:10.1136/bmj.j1855 · Cited by 53
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
Hartung, D. M., Johnston, K. A., Cohen, D., Nguyen, T. D., Deodhar, A. A., & BOURDETTE, D. N. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0482 · Cited by 52
Mitchell, A. P., Winn, A. N., Lund, J. L., & Dusetzina, S. B. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0423 · Cited by 51
Self-citationEffect of Physician Payment Disclosure Laws on Prescribing
Kanter, G. P., Alexander, G. C., & Nair, K. V. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1210 · Cited by 49
Zezza, M. A., & Bachhuber, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209383 · Cited by 44
Liang, F., Zhu, J., Mo, M., Zhou, C., Jia, H., Xie, L., Zheng, Y., & Zhang, S. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy305 · Cited by 41
Pharmaceutical payments to physicians may increase prescribing for opioids
Nguyen, T. D., Bradford, W. D., & Simon, K. I. (2019) · Addiction · doi:10.1111/add.14509 · Cited by 41
Khan, R., Nugent, C. M., Scaffidi, M. A., Gimpaya, N., & Grover, S. C. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0999 · Cited by 34
Brunt, C. S. (2018) · Health Services Research · doi:10.1111/1475-6773.13064 · Cited by 28
Association Between Industry Payments to Physicians and Gabapentinoid Prescribing
Rhee, T. G., & Ross, J. S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.1082 · Cited by 27
Inoue, K., Figueroa, J. F., Orav, E. J., & Tsugawa, Y. (2020) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2020-214021 · Cited by 27
Conflict of Interest and the Integrity of the Medical Profession
Lichter, A. S. (2017) · JAMA · doi:10.1001/jama.2017.3191 · Cited by 26
Physicians, Industry Payments for Food and Beverages, and Drug Prescribing
Steinbrook, R. (2017) · JAMA · doi:10.1001/jama.2017.2477 · Cited by 26
Qian, J., Hansen, R. A., Surry, D. W., Howard, J. N., Kiptanui, Z., & Harris, I. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4224 · Cited by 26
Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids
Fleischman, W. M., Agrawal, S., Gross, C. P., & Ross, J. S. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-04897-9 · Cited by 25
Industry Payments to Physicians and Prescriptions of Brand‐Name Proton‐Pump Inhibitors
Morse, E., Fujiwara, R. J. T., & Mehra, S. (2018) · Otolaryngology · doi:10.1177/0194599818803337 · Cited by 24
Scope and nature of financial conflicts of interest between neurologists and industry
Robbins, N. M., Meyer, M. J., & Bernat, J. L. (2019) · Neurology · doi:10.1212/wnl.0000000000008067 · Cited by 24
Hollander, M. A. G., Donohue, J. M., Stein, B. D., Krans, E. E., & Jarlenski, M. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05470-0 · Cited by 24
The relation between promotional spending on drugs and their therapeutic gain: a cohort analysis
Lexchin, J. (2017) · CMAJ Open · doi:10.9778/cmajo.20170089 · Cited by 23
Morse, E., Fujiwara, R. J. T., & Mehra, S. (2018) · Otolaryngology · doi:10.1177/0194599818774739 · Cited by 23
Cole, A. L., Wood, W. A., Muluneh, B., Lund, J. L., Lafata, J. E., & Dusetzina, S. B. (2020) · JCO Oncology Practice · doi:10.1200/jop.19.00301 · Cited by 21
Conflicts of interest in pain medicine: Practice patterns and relationships with industry
Schofferman, J. A., & Banja, J. D. (2008) · Pain · doi:10.1016/j.pain.2008.08.016 · Cited by 19
Fujiwara, R. J. T., Shih, A. F., & Mehra, S. (2017) · Otolaryngology · doi:10.1177/0194599817728897 · Cited by 19
The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab
Bandari, J., Turner, R. M., Jacobs, B. L., Canes, D., Moinzadeh, A., & Davies, B. (2016) · Urology Practice · doi:10.1016/j.urpr.2016.03.007 · Cited by 17
Eisenberg, M. D., Stone, E. M., Pittell, H., & McGinty, E. E. (2020) · Health Affairs · doi:10.1377/hlthaff.2019.01289 · Cited by 17
Freemantle, N., Johnson, R. E., Dennis, J. A., Kennedy, A. D. M., & Marchment, M. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00126.x · Cited by 13
Mahr, M. A., Hodge, D. O., & Erie, J. C. (2016) · Ophthalmology Retina · doi:10.1016/j.oret.2016.08.001 · Cited by 13
Provider-directed marketing may increase prescribing of medications for opioid use disorder
Nguyen, T. D., Andraka‐Christou, B., Simon, K. I., & Bradford, W. D. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.06.014 · Cited by 13
Hayes, M. J., & Prasad, V. K. (2019) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2019.100189 · Cited by 12
The Association between Industry Payments and Brand‐Name Prescriptions in Otolaryngologists
Morse, E., Hanna, J. M., & Mehra, S. (2019) · Otolaryngology · doi:10.1177/0194599819852321 · Cited by 12
Elsamadicy, A. A., Freedman, I. G., Koo, A. B., Reeves, B. C., Havlik, J., David, W. B., Hong, C. S., Kolb, L. E., Laurans, M. S. H., Matouk, C. C., et al. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.09.137 · Cited by 12
Singh, P., Forman, H. P., Adamson, A. S., Mostaghimi, A., Ogdie, A., Oganisian, A., & Barbieri, J. S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4698-x · Cited by 11
Serhiyenko, V., Равишанкер, Н., & Venkatesan, R. (2017) · Applied Stochastic Models in Business and Industry · doi:10.1002/asmb.2232 · Cited by 7
Exploring the link between industry payments to doctors and prescribing habits
Carlat, D. (2014) · BMJ · doi:10.1136/bmj.g6651 · Cited by 5
Ichikawa, I., & Clayton, E. W. (2016) · Accountability in Research · doi:10.1080/08989621.2016.1144478 · Cited by 4
Mehta, H. B., Moore, T. J., & Alexander, G. C. (2020) · Psychiatric Services · doi:10.1176/appi.ps.202000251 · Cited by 4
Receiving Industry Payments is Associated with Prescribing Habits of Tadalafil
Chua, K. J., Li, G., Stahl, P. J., & Hyams, E. S. (2019) · Urology Practice · doi:10.1097/upj.0000000000000017 · Cited by 3
Physician-Industry Interactions: There is No Such Thing as a Free Lunch
Tsai, H.-J. (2008) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(08)60098-4 · Cited by 2
Cited by
Galderisi, S., Appelbaum, P. S., Gill, N., Gooding, P., Herrman, H., Melillo, A., Myrick, K., Pathare, S., Savage, M., Szmukler, G., et al. (2024) · World Psychiatry · doi:10.1002/wps.21230 · Cited by 76
Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science
Sismondo, S. (2021) · Frontiers in Research Metrics and Analytics · doi:10.3389/frma.2021.614013 · Cited by 63
Mapping conflict of interests: scoping review
Chimonas, S., Mamoor, M., Zimbalist, S. A., Barrow, B., Bach, P. B., & Korenstein, D. (2021) · BMJ · doi:10.1136/bmj-2021-066576 · Cited by 54
Self-citationOff-Label Use vs Off-Label Marketing of Drugs
Van Norman, G. A. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.011 · Cited by 49
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?
Mitchell, A., Sarpatwari, A., & Bach, P. B. (2022) · Journal of Health Politics, Policy and Law · doi:10.1215/03616878-10041205 · Cited by 16
Self-citation
Metadata
- Authors
- Mitchell, A. P., Trivedi, N. U., Gennarelli, R. L., Chimonas, S., Tabatabai, S. M., Goldberg, J., Diaz, L. A., & Korenstein, D.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2021-03
- Volume
- 174
- Issue
- 3
- Pages
- 353-361
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3107325929
- Cited by
- 262
- References
- 78
- FWCI
- 23.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.